Additional functions for the cysteinyl leukotrienes recognized through studies of inflammatory processes in null strains

Prostaglandins and Other Lipid Mediators

Volumn 83, Issue 3 SPEC. ISS., 2007, Pages 182-187

  Austen, K Frank ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adaptive immune response; Chronic inflammatory cell responses; Cysteinyl leukotrienes

Indexed keywords

ANTIGEN; PEPTIDOLEUKOTRIENE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MOTONEURON; MOUSE; MOUSE STRAIN; NONHUMAN; NULL ALLELE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SENSORY NERVE CELL;

EID: 34247521882     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2007.01.004     Document Type: Article

References (35)

1. Brocklehurst W.E. The release of histamine and formation of slow reacting substance (SRS-A) during anaphylactic shock. J Physiol 151 (1960) 416-435
2. Stechschulte D.J., Austen K.F., and Bloch K.J. Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat. J Exp Med 125 (1967) 127-147
3. Orange R.P., Stechschulte D.J., and Austen K.F. Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic release of histamine and slow reacting substance of anaphylaxis (SRS-A). J Immunol 105 (1970) 1087-1095
4. Ishizaka T., Ishizaka K., Orange R.P., and Austen K.F. The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung. J Immunol 104 (1970) 335-343
5. Orange R.P., Austen W.G., and Austen K.F. Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′,5′-adenosine monophosphate. J Exp Med 134 (1971) 136-148
6. Murphy R.C., Hammarström S., Samuelsson B., and Leukotriene C. A slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76 (1979) 4275-4279
7. Woods J.W., Evans J.F., Ethier D., et al. 5-Lipoxygenase and 5-lipoxygenase activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med 178 (1993) 1935-1946
8. Woods J.W., Coffey M.J., and Brock T.G. Singer II, Peters-Golden M, 5-lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J Clin Invest 95 (1995) 2035-2046
9. 2 hydrolase. Proc Natl Acad Sci USA 84 (1987) 6677-6681
10. 4 synthase of guinea pig lung. J Clin Invest 81 (1988) 866-871
11. 4. Proc Natl Acad Sci USA 91 (1994) 7663-7667
12. 4 synthesis in vivo and attenuation of the acute inflammatory response. Mol Cell Biol 21 (2001) 5389-5395
13. 4 synthase. Eur J Biochem 238 (1996) 606-612
14. 4 synthase. Proc Natl Acad Sci USA 91 (1994) 9745-9749
15. 4 synthase: organization, nucleotide sequence, and chromosomal localization to 5q35. J Biol Chem 271 (1996) 11356-11361
16. 4 synthase. J Biol Chem 272 (1997) 13923-13928
17. 4 synthase. J Biol Chem 276 (2001) 22608-22613
18. 1 receptor. Nature 399 (1999) 789-793
19. Heise C.E., O'Dowd B.F., Figueroa D.J., et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275 (2000) 30531-30536
20. Maekawa A., Kanaoka Y., Lam B.K., and Austen K.F. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc Natl Acad Sci USA 98 (2001) 2256-2261
21. 1) receptor. Biochem Pharmacol 62 (2001) 1193-1200
22. 2) receptor: cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 276 (2001) 47489-47495
23. Maekawa A., Austen K.F., and Kanaoka Y. Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem 277 (2002) 20820-20824
24. Beller T.C., Maekawa A., Friend D.S., Austen K.F., and Kanaoka Y. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem 44 (2004) 46129-46134
25. Nagase T., Uozumi N., Ishii S., et al. A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat Med 8 (2002) 480-484
26. Peters-Golden M., Bailie M., Marshall T., et al. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 165 (2002) 229-235
27. Beller T.C., Friend D.S., Maekawa A., Lam B.K., Austen K.F., and Kanaoka Y. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci USA 101 (2004) 3047-3052
28. Irvin C.G., Tu Y.P., Sheller J.R., and Funk C.D. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am J Physiol 272 (1997) L1053-L1058
29. Tager A.M., Bromley S.K., Medoff B.D., et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4 (2003) 982-990
30. Henderson Jr. W.R., Lewis D.B., Albert R.K., et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 184 (1996) 1483-1494
31. Chvatchko Y., Kosco-Vilbois M.H., Herren S., Lefort J., and Bonnefoy J.Y. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J Exp Med 184 (1996) 2353-2360
32. Williams C.M., and Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192 (2000) 455-462
33. Kim D.C., Hsu F.I., Barrett N.A., et al. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammtion. J Immunol (2006) 4440-4448
34. Mellor E.A., Austen K.F., and Boyce J.A. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin-4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 195 (2002) 583-592
35. Mellor E.A., Frank N., Soler D., et al. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R. Proc Natl Acad Sci USA 100 (2003) 11589-11593